Vertex Pharmaceuticals Net Non-Operating Interest Income Expense (Quarterly) Analysis

Vertex Pharmaceuticals, Inc. (VRTX)

459.78 -3.12 (-0.67%) USD | NASDAQ | Dec 29, 16:00

459.63 -0.15 (-0.03%) Pre-Market: 09:19

View Net Non-Operating Interest Income Expense (Quarterly) for VRTX.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Net Non-Operating Interest Income Expense (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Net Non-Operating Interest Income Expense (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Net Non-Operating Interest Income Expense (Quarterly) Benchmarks

Start Trial

Pfizer Inc.	Upgrade
Amgen, Inc.	Upgrade
Eli Lilly & Co.	Upgrade
IDEXX Laboratories, Inc.	Upgrade
Regeneron Pharmaceuticals, Inc.	Upgrade